Employer Enthusiasm For Disease Management Is Waning, Insurers Say
This article was originally published in The Pink Sheet Daily
Executive Summary
PBMI Prescription Drug Utilization Conference attendees express caution about the motives of pharmaceutical manufacturer-sponsored disease management programs. Preliminary results from PBMI’s 2005 benefit design report found that a lower percentage of employers are using disease management programs.
You may also be interested in...
Disease Management Will Yield More Savings In Medicare Than Private Plans, CMS Says
Medicare beneficiaries offer a more stable population with a greater number of chronic diseases than those in private plans, CMS’ Guterman says. Current expectations about possible returns on investment from disease management programs are too high, Disease Management Purchasing Consortium says.
Disease Management Will Yield More Savings In Medicare Than Private Plans, CMS Says
Medicare beneficiaries offer a more stable population with a greater number of chronic diseases than those in private plans, CMS’ Guterman says. Current expectations about possible returns on investment from disease management programs are too high, Disease Management Purchasing Consortium says.
Medicare Chronic Disease Management Pilots To Begin In Spring 2005
HHS selects nine organizations to coordinate care for 180,000 Medicare beneficiaries with congestive heart failure, complex diabetes and chronic obstructive pulmonary disease. The programs will be evaluated through randomized controlled trials.